Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population

International Journal of Obesity volume 31, pages 908–912 (2007)Cite this article

Abstract

Context:

Endocannabinoids control food intake via both central and peripheral mechanisms, and cannabinoid type-1 receptor (CB1) modulates lipogenesis in primary adipocyte cell cultures and in animal models of obesity.

Objectives:

We aimed to evaluate, at the population level, the frequency of a genetic polymorphism of CB1 and to study its correlation with body mass index.

Design, setting and participants:

Healthy subjects from a population survey carried out in southern Italy examined in 1992–1993 and older than 65 years (n=419, M=237, F=182) were divided into quintiles by body mass index (BMI). Two hundred and ten subjects were randomly sampled from the first, third and fifth quintile of BMI (BMI, respectively: 16.2–23.8=normal, 26.7–28.4=overweight, 31.6–49.7=obese) to reach a total of 70 per quintile. Their serum and white cells from the biological bank were used to measure the genotype and the blood variables for the study.

Measurements:

Anthropometric parameters, blood pressure, serum glucose and lipid levels were measured with standard methods; genotyping for the CB1 1359G/A polymorphism was performed using multiplex PCR. Statistical methods included χ2 for trend, binomial and multinomial multiple logistic regression to model BMI on the genotype, controlling for potential confounders.

Results:

We found a clear trend of increasing relative frequency of the CB1 wild-type genotype with the increase of BMI (P=0.03) and, using a multiple logistic regression model, wild-type genotype, female gender, age, glycaemia and triglycerides were directly associated with both overweight (third quintile of BMI) and obesity (fifth quintile of BMI).

Conclusions:

Although performed in a limited number of subjects, our results show that the presence of the CB1 polymorphic allele was significantly associated with a lower BMI.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a World Health Organization consultation on obesity. WHO: Geneva, 1997.

  2. Wolf AM . What is the economic case for treating obesity? Obes Res 1998; 6: 2S–7S.

    Article  Google Scholar 

  3. Cota D, Marsicano G, Tschöp M, Grubler Y, Flachskamm C, Schubert M et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003; 112: 423–431.

    Article  CAS  Google Scholar 

  4. Felder CC, Glass M . Cannabinoid receptors and theirendogenous agonists. Ann Rev Pharmacol Toxicol 1998; 38: 179–200, Review.

    Article  CAS  Google Scholar 

  5. Ravinet TC, Delgorge C, Menet C, Arnone M, Soubrie P . CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004; 28: 640–648.

    Article  Google Scholar 

  6. Harrold JA, Elliott JC, King PJ, Widdowson PS, Williams G . Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 2002; 952: 232–238.

    Article  CAS  Google Scholar 

  7. Poirier B, Bidouard JP, Cadrouvele C, Marniquet X, Staels B, O’Connor SE et al. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes, Obes Metab 2005; 7: 65–72.

    Article  CAS  Google Scholar 

  8. Sipe JC, Waalen J, Gerber A, Beutler E . Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes Relat Metab Disord 2005; 29: 755–759.

    Article  CAS  Google Scholar 

  9. Gadzicki D, Muller-Vahl K, Stuhrmann M . A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Mol Cell Probes 1999; 13: 321–323.

    Article  CAS  Google Scholar 

  10. Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki JB, Rommelspacher H et al. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 2002; 65: 221–224.

    Article  CAS  Google Scholar 

  11. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 2003; 63: 908–914.

    Article  CAS  Google Scholar 

  12. Engeli S, Jana B, Mareike F, Kerstin G, Jürgen J, Sándor B et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005; 54: 2838–2843.

    Article  CAS  Google Scholar 

  13. Jbilo O, Ravinet-Trillou C, Arnone M, Buisson I, Bribes E, Peleraux A et al. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 2005; 19: 1567–1569.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Benedetta D’Attoma for her technical assistance, C Proto for her help and support, and A Santoro for critically reading the manuscript. We thank the Association ‘Educazione e Ricerca Medica Salernitana’ (ERMES) and Sanofi-Aventis Research for supporting our studies on this subject. The sponsors of this study had no role in study design, data collection, data analysis, data interpretation or writing of the report.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, University of Salerno, Fisciano, Italy

    P Gazzerro & M Bifulco

  2. Laboratory of Biochemistry, IRCCS ‘Saverio de Bellis’, Via della Resistenza, Castellana Grotte, Bari, Italy

    M G Caruso & M Notarnicola

  3. Laboratory of Epidemiology and Biostatistics, IRCCS ‘Saverio de Bellis’, Via della Resistenza, Castellana Grotte, Bari, Italy

    G Misciagna & V Guerra

  4. Institute of Endocrinology and Experimental Oncology – CNR, Napoli, Italy

    C Laezza

  5. Department of Cellular and Molecular Biology and Pathology, University ‘Federico II’, Napoli, Italy

    C Laezza

Authors
  1. P Gazzerro
    View author publications

    Search author on:PubMed Google Scholar

  2. M G Caruso
    View author publications

    Search author on:PubMed Google Scholar

  3. M Notarnicola
    View author publications

    Search author on:PubMed Google Scholar

  4. G Misciagna
    View author publications

    Search author on:PubMed Google Scholar

  5. V Guerra
    View author publications

    Search author on:PubMed Google Scholar

  6. C Laezza
    View author publications

    Search author on:PubMed Google Scholar

  7. M Bifulco
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to M Bifulco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gazzerro, P., Caruso, M., Notarnicola, M. et al. Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population. Int J Obes 31, 908–912 (2007). https://doi.org/10.1038/sj.ijo.0803510

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803510

Keywords

This article is cited by

Search

Advanced search

Quick links